IRIG yields 4000.00% · JNJ yields 2.13%● Live data
📍 IRIG pulled ahead of the other in Year 1
Combined, IRIG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRIG + JNJ for your $10,000?
Integrated Drilling Equipment Holdings Corp. manufactures drilling rigs, rig control systems, and rig components; and provides rig refurbishment and reconfiguration services for contract drilling companies worldwide. It operates through two segments, Electrical Products and Services, and Drilling Products and Services. The Electrical Products and Services segment designs, manufactures, installs, and services rig electrical and control systems, such as silicon controlled rectifier units, variable frequency drive units, electrical cabling, lighting systems, closed circuit video systems, gas and fire detection systems, and communication systems. This segment also offers rig power systems, AC and DC drive systems and MCC, electrical rig up, engine generators, automation, controls/sensors, hydraulic power units, other rig related hydraulic solutions, system integration, hydraulic system design, testing, and rig up/support products and services. The Drilling Products and Services segment provides drilling rigs and components. This segment designs, manufactures, and services land-based drilling rigs, and rig subsystems and parts; offers drilling rig services comprising mechanical services, assembly testing, rig refurbishment and inspection, new rig fabrication, and completion of land rig packages; and fabricates mud tanks, masts and substructures, dog houses, and other drilling rig related products. Integrated Drilling Equipment Holdings Corp. is headquartered in Spring, Texas.
Full IRIG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.